Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Intelgenx Technologies Corp T.IGX

Alternate Symbol(s):  IGXT

IntelGenx Technologies Corp. is a Canada-based drug delivery company. The Company provides single-site, end-to-end contract development and manufacturing services of oral thin film and transdermal drug products for the pharmaceutical and animal health markets, spanning the entire drug development and commercial product cycle. The Company’s film technologies, including VersaFilm, DisinteQ, VetaFilm and transdermal VevaDerm, allows for pharmaceutical products that address unmet medical needs. It provides comprehensive pharmaceuticals services to pharmaceutical partners, including research and development (R&D), analytical method development, clinical monitoring, IP and regulatory services. Its manufacturing facility offers full service by providing lab-scale to pilot- and commercial-scale production. Its product portfolio includes Migraine (Rizatriptan), Erectile Dysfunction (Tadalafil), Schizophrenia (Lozapine), Neurodegenerative, Opioid Dependence (Buprenorphine / Naloxone) and others.


TSX:IGX - Post by User

Post by Betteryear2on Oct 05, 2021 2:43pm
351 Views
Post# 33968111

Receive Final Approval to Graduate to Toronto Stock Exchange

Receive Final Approval to Graduate to Toronto Stock Exchange

SAINT LAURENT, Quebec, Oct. 05, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV: IGX) (OTCQB: IGXT) (“IntelGenx” or ”the “Company”) announces that it has received final approval to graduate to the Toronto Stock Exchange (the “TSX”) from the TSX Venture Exchange (the “TSXV”). The Company’s shares of common stock (the “Common Shares”), 8% convertible debentures with a maturity date of June 30, 2022 (the “Convertible Debentures”), and share purchase warrants expiring on February 11, 2023 (the “Warrants”) are expected to commence trading on the TSX at market open on Thursday, October 7, 2021 under the existing stock symbols “IGX”, “IGX.DB” and “IGX.WT”, respectively.

“The TSX is Canada's most prestigious and senior exchange,” commented Dr. Horst G. Zerbe, CEO of IntelGenx. “This graduation marks an important milestone for IntelGenx, and we believe that it will help us develop a stronger profile in the investment community.”

The Common Shares, Convertible Debentures and Warrants will be delisted from the TSXV concurrently with the commencement of trading on the TSX. Holders of Common Shares, Convertible Debentures and Warrants are not required to take any action in connection with the graduation.


https://www.globenewswire.com/news-release/2021/10/05/2309102/0/en/IntelGenx-Receives-Final-Approval-to-Graduate-to-Toronto-Stock-Exchange.html
<< Previous
Bullboard Posts
Next >>